Results 241 to 250 of about 38,480 (291)

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study). [PDF]

Front Pharmacol
Montero-Balosa MC, Limón-Mora JA, Leal-Atienza A, García-Robredo B, Sánchez-Villegas P, Isabel-Gómez R, Aguado-Romeo MJ, Luque Romero LG, Molina-López MT.   +8 more
europepmc   +1 more source

Evaluating the Effect of Concomitant Azoles on Anticoagulant Prescribing Practices in Transplant Patients: A National Survey of Clinicians. [PDF]

J Pharm Technol
Burroughs KM, Lichvar AB, Groetzinger LM, Horn E, Iasella CJ, Moore CA, Pierce DR, Sacha LM, Rivosecchi RM.   +8 more
europepmc   +1 more source

Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with liver disease: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Zhou Q, Liu X, Liu S, Gu Z, Wu Y, Yang Y, Tao Y, Wei M.   +7 more
europepmc   +1 more source

Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy. [PDF]

Res Pract Thromb Haemost
Foulon-Pinto G, Jourdi G, Delrue M, Lafuente-Lafuente C, Cavalie C, Gouin-Thibault I, Le Guen J, Gaussem P, Mirault T, Puymirat E, Lecompte T, Pautas E, Curis E, Siguret V.   +13 more
europepmc   +1 more source

Apixaban- and Rivaroxaban-Associated Bleeding: A Retrospective Analysis Using the FDA Adverse Event Reporting System. [PDF]

Cureus
Logvinsky IK, Sanchez C, Ciuciureanu C, Wu E, El Aryan O, Delibasic M.   +5 more
europepmc   +1 more source

Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis [PDF]

, 2017
Hindricks, Gerhard, Steffel, Jan
core  

Optimal Timing of Oral Anticoagulant Therapy Initiation Post-acute Ischemic Stroke: A Narrative Review. [PDF]

Cureus
Aderinto N, Aljamea LH, Aljamea FH.
europepmc   +1 more source

Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile. [PDF]

Cost Eff Resour Alloc
Abbot T, Armijo N, Orellana LR, Jiménez AG, Balmaceda C, Espinoza M.   +5 more
europepmc   +1 more source

Comparative risk of osteoporotic fractures with direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients: a systematic review. [PDF]

Int J Burns Trauma
Mojahedi A, Singh A, Sadeghian A, Chen O.   +3 more
europepmc   +1 more source